skin grafts Articles
-
Treatment Considerations for Pediatric Deep Soft Tissue Injuries
Treatment of pediatric soft tissue wounds presents additional complexities and highlights unique requirements. This piece provides a synopsis of an article [1] published in the Journal of Pediatric Surgery Case Reports by Dr. Kyle Crowley and his colleagues from the Division of Paediatric Surgery at Townsville University Hospital in Queensland, Australia. NovoSorb® BTM, a biodegradable ...
-
What Are the 6 Steps for the Use of NovoSorb BTM?
NovoSorb® BTM (Biodegradable Temporizing Matrix) is a biocompatible device designed to temporize dermal injuries where tissue has been decimated or lost and to facilitate dermal repair by providing temporary wound closure and a scaffold for the generation of new dermal tissue. NovoSorb BTM is intended for single application and shouldn’t be applied into overtly infected wounds. ...
-
Controlling Intraoperative Hemorrhage During Burn Surgery: A Prospective, Randomized Trial Comparing NuStat Hemostatic Dressing to the Historic Standard of Care
Introduction: One of the primary intraoperative challenges during burn surgery is to adequately excise the burn while avoiding massive hemorrhage. This has become increasingly important, as we see more burn patients that are older and with more medical comorbidities. While adequate excision down to healthy tissues for deep burns is essential for skin graft to take, it also leads to active ...
-
Uses of Recombinant Human Collagen
Collagen is the main structural protein in vertebrates. It plays an essential role in providing a scaffold for cellular support and thereby affecting cell attachment, migration, proliferation, differentiation, and survival. Natural animal collagen and its recombinant collagen are favorable replacements in human tissue engineering due to their remarkable biomedical property. However, this ...
-
Introducing CellQART Cell Culture Inserts: Giving New Life to Tissue Engineering
The new line of cellQART cell culture inserts, offered by Sterlitech, have important applications in medical science. Cell culture inserts have been used widely in tissue engineering because they allow access to both sides of the membrane. Each insert is designed to fit inside the well of a culture plate, making it more effective for growing 3D tissue layers than seeding cells directly on the ...
-
5 FAQs to Know about Using NovoSorb BTM
Whether you are a first-time user or an expert in NovoSorb® BTM (Biodegradable Temporizing Matrix) for dermal repair and reconstruction, we’re here to answer questions you may have regarding its use in a clinical setting. Below you’ll find answers to the questions we get asked the most regarding the use of NovoSorb BTM. 1. How Long Does It Take for BTM to Fully Integrate with the ...
-
HBOT for Complementary Therapy
If you’re considering HBOT, it’s important to understand the benefits and risks this therapy entails. The treatment should be discussed with a certified healthcare professional to develop a plan of action based on scientific evidence and tailored to your exact condition. Hyperbaric oxygen therapy can be used as complementary therapy to address several medical problems. The theory ...
-
Essential Facts about NovoSorb BTM
When trauma to the skin occurs, large areas of both the skin’s surface (epidermis) and deeper layers (dermis) may be destroyed. In many cases, large full-thickness wounds may require temporization due to the lack of suitable donor sites for primary skin grafting. Clinical research[1] indicates the temporization of deep, large wounds with dermal scaffolds can not only help provide ...
-
7 Advantages of NovoSorb BTM
Complex wounds often involve exposed deep structures of the dermal layer, requiring prompt wound closure and tissue reconstruction. It is essential to quickly assess the defect and identify the most effective treatment method for optimizing the patient’s experience and outcome. Often, dermal substitutes are selected as a surgical option for temporizing the wound bed while also facilitating ...
-
LimFlow Percutaneous Deep Venous Arterialization
What interested you in LimFlow, and how did you get involved in the PROMISE I trial? Dr. Clair: Practicing vascular surgery, where a number of patients are evaluated for chronic limb-threatening ischemia (CLTI), you are guaranteed to have patients who are not candidates for percutaneous or surgical revascularization. These patients often have arterial systems open or identifiable to the ankle, ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you